A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors
Clinical trial NCT04200404 · COMPLETED
Trial details
- NCT number
- NCT04200404
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-13
- Primary completion
- 2021-05-13
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.